Mifepristone treatment improves length and quality of survival of mice with spontaneous leukemia

Anticancer Research

Volumn 29, Issue 8, 2009, Pages 2977-2980

  Check, Jerome H ^a,b   Sansoucie, Lynn ^a   Chern, Joshua ^a   Amadi, Nkechinyere ^a   Katz, Youval ^a  

^a UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^b Department of Medicine ^*  (United States)

Author keywords

Mifepristone; Murine leukemia; Progesterone receptor antagonist

Indexed keywords

MIFEPRISTONE; OLIVE OIL; PROGESTERONE INDUCED BLOCKING FACTOR; PROGESTERONE RECEPTOR; PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY CONSTITUTION; CANCER SURVIVAL; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; LYMPHATIC LEUKEMIA; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUALITY OF LIFE;

ANIMALS; HORMONE ANTAGONISTS; LEUKEMIA; MICE; MICE, INBRED AKR; MIFEPRISTONE; PLANT OILS; RECEPTORS, PROGESTERONE; SURVIVAL RATE; TIME FACTORS;

EID: 68549125196     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Pence H, Petty WM and Rocklin RE: Suppression of maternal responsiveness to paternal antigens by maternal plasma. J Immunol 114: 525-528, 1975.
2. Szekeres-Bartho J, Kilar F, Falkay G, Csernus V, Torok A and Pacsa AS: The mechanism of the inhibitory effect of progesterone on lymphocyte cytotoxicity: I. Progesterone-treated lymphocytes release a substance inhibiting cytotoxicity and prostaglandin synthesis. Am J Reprod Microbiol 9: 15-18, 1985. (Pubitemid 15250397)
3. Szekeres-Bartho J, Autran B, Debre P, Andreu G, Denver L and Chaouat G: Immunoregulatory effects of a suppressor factor from healthy pregnant women's lymphocytes after progesterone induction. Cell Immunol 122: 281-294, 1989. (Pubitemid 19232469)
4. Szekeres-Bartho J, Barakonyi A, Polgar B, Par G, Faust Z, Palkovics T and Szeresay L: The role of gamma/delta T-cells in progesterone-mediated immunomodulation during pregnancy: a review. Am J Reprod Immunol 42: 44-48, 1999. (Pubitemid 29308533)
5. Szekeres-Bartho J, Csernus V and Hadnagy J: The blocking effect of progesterone on lymphocyte responsiveness is receptor-mediated. Biol Immunol Reprod 15: 36, 1989.
6. Szekeres-Bartho J, Szekeres G, Debre P, Autran B and Chaouat G: Reactivity of lymphocytes to a progesterone receptor specific monoclonal antibody. Cell Immunol 125: 273-283, 1990. (Pubitemid 20058487)
7. Chiu L, Nishimura M, Ishii Y, Nieda M, Maeshima M, Takedani Y, Shibata Y, Tadokoro K and Juji T: Enhancement of the expression of progesterone receptor on progesterone treated lymphocyte after immunotherapy in unexplained recurrent spontaneous abortion. Am J Reprod Immunol 35: 552-557, 1996. (Pubitemid 26172355)
8. Szekeres-Bartho J, Weill BJ, Mike G, Houssin D and Chaouat G: Progesterone receptors in lymphocytes of liver-transplanted and transfused patients. Immunol Lett 22: 259-261, 1989. (Pubitemid 19233464)
9. Check JH, Arwitz M, Gross J, Peymer M and Szekeres Bartho J: Lymphocyte immunotherapy (LI) increases serum levels of progesterone induced blocking factor. Am J Reprod Immunol 37: 17-20, 1997. (Pubitemid 27075964)
10. Faust Z, Laskarin G, Rukavina D and Szekeres-Bartho J: Progesterone induced blocking factor inhibits degranulation of natural killer cells. Am J Reprod Immunol 42: 71-75, 1999.
11. Szekeres-Bartho J, Varga P and Pejtsik B: ELISA test for the detection of an immunological blocking factor in human pregnancy serum. J Reprod Immunol 16: 19-29, 1989. (Pubitemid 19263330)
12. Szekeres-Bartho J, Faust Z and Varga P: The expression of a progesterone-induced immunomodulatory protein in pregnancy lymphocytes. Am J Reprod Immunol 34: 342-348, 1995.
13. Check JH, Ostrzenski A and Klimek R: Expression of an immunomodulatory protein known as progesterone induced blocking factor (PIBF) does not correlate with first trimester spontaneous abortions in progesterone supplemented women. Am J Reprod Immunol 37: 330-334, 1997.
14. Check JH, Nazari P, Goldberg J, Yuen W and Angotti D: A model for potential tumor immunotherapy based on knowledge of immune mechanisms responsible for spontaneous abortion. Med Hypoth 57: 337-343, 2001. (Pubitemid 32822431)
15. Acevedo HF, Tong JY and Hartsock RJ: Human chorionic gonadotropin-beta subunit gene expression in cultured human fetal and cancer cells of different types and origins. Cancer 76: 1467-1475, 1995.
16. Acevedo HF, Longinotti SM and Marquardt M: Expression of hCG, its subunits and fragments by human cultured cancer cells of the nervous system. Cancer Detect Prevent 19: 37, 1995.
17. Srivastava MD, Thomas A, Srivastava BIS and Check JH: Expression and modulation of progesterone induced blocking factor (PIBF) and innate immune factors in human leukemia cell lines by progesterone and mifepristone. Leuk Lymph 48(8): 1610-1617, 2007. (Pubitemid 47272811)
18. Dubois C, Ulmann A and Baulieu EE: Contragestion with late luteal administration of RU486 (mifepristone). Fertil Steril 50: 593-596, 1988. (Pubitemid 18248540)
19. Lahteenmaki P, Rapeli T, Kaariainen M, Alfthan H and Ylikorkala O: Late postcoital treatment against pregnancy with antiprogesterone RU486. Fertil Steril 50: 36-38, 1988. (Pubitemid 18188895)
20. Bygdeman M and Swahn ML: Progesterone receptor blockage: effect on uterine contractility and early pregnancy. Contraception 32: 45-51, 1985. (Pubitemid 15227618)
21. Lui WY, Chi CW, Chang YF, Chu HW, Hsieh CC, Yin PH, Liu TY, Ou YR and P'eng FK: In vivo and in vitro growth stimulation of murine hepatoma cells by glucocorticoid. Anticancer Res 22: 1413-1422, 2002.